ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,206Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 334

$2.09M Total Retail Price of All Prescriptions

Rank: 4 out of 334

986 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 3,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
RISPERIDONE 1,786 409 10 1 2
TRAZODONE HCL 1,043 125 2 1
CITALOPRAM HBR 965 303 3 4
CYMBALTA 844 161 4 3
FLUOXETINE HCL 834 195 5 11
DIVALPROEX SODIUM ER 690 25 6 14
HYDROXYZINE PAMOATE 653 71 R 10 7 22
SERTRALINE HCL 617 165 8 10
QUETIAPINE FUMARATE 612 162 9 7
BENZTROPINE MESYLATE 556 25 R 10 9
ABILIFY 538 118 11 5
ZOLPIDEM TARTRATE 514 40 12 8
LAMOTRIGINE 505 36 13 6
BUSPIRONE HCL 472 141 14 20
VENLAFAXINE HCL ER 411 43 15 12
OLANZAPINE 354 69 16 15
AMITRIPTYLINE HCL 341 15 R 17 43
HALOPERIDOL 338 0 18 24
NAMENDA 338 283 18 33
DIVALPROEX SODIUM 335 79 20 26
TOPIRAMATE 315 0 21 28
MIRTAZAPINE 300 103 22 13
DONEPEZIL HCL 300 248 22 38
DOXEPIN HCL 288 17 24 44
SEROQUEL 279 59 25 27
CHLORPROMAZINE HCL 273 0 26 49
ZIPRASIDONE HCL 270 0 27 30
BUPROPION XL 242 0 28 16
PAROXETINE HCL 235 34 29 23
LITHIUM CARBONATE 233 0 30 18
SEROQUEL XR 233 32 30 25
GABAPENTIN 232 32 32 29
ESCITALOPRAM OXALATE 228 63 33 17
PRISTIQ ER 193 19 34 31
TRIHEXYPHENIDYL HCL 186 43 R 35 42
OXCARBAZEPINE 167 26 36 32
ZYPREXA 154 28 37 48
INVEGA 145 0 38 34
LUNESTA 143 18 39 40
CARBAMAZEPINE 132 0 40 39
PERPHENAZINE 122 12 41 65
VENLAFAXINE HCL 116 0 42 55
CLOZAPINE 106 0 43 19
BUPROPION HCL SR 105 12 44 21
RISPERDAL CONSTA 98 0 45 36
HYDROXYZINE HCL 92 0 R 46 57
LEXAPRO 92 32 46 45
GABITRIL 91 20 10 48 115
GEODON 90 0 49 66
INVEGA SUSTENNA 86 21 50 35
ISOSORBIDE MONONITRATE ER 85 59 51 118
FLUVOXAMINE MALEATE 83 0 52 63
BUPROPION HCL 81 18 53 71
PROPRANOLOL HCL 80 0 54 46
METOPROLOL TARTRATE 66 34 55 112
THIORIDAZINE HCL 63 0 R 56 93
STRATTERA 62 0 57 90
LISINOPRIL 55 26 58 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.